CBLL חוב כולל להון CeriBell

The CeriBell, Inc. (CBLL) total debt-to-equity ratio chart stands at 0.16. Stable business revenue is secured by linking medical centers to proprietary consumables for EEG systems. Further growth relies on insurance companies recognizing monitoring effectiveness and the implementation of AI in intensive care units. High demand for rapid stroke diagnostic software allows the company to maintain its pricing power.

This ratio is calculated as total liabilities divided by equity, measuring the business's degree of dependence on borrowed funds. The metric's trend depends directly on the balance sheet structure and the volume of raised financing. By analyzing the current leverage ratio (total debt to equity), an investor assesses the risk of bankruptcy or the potential for expansion. For CeriBell, Inc. (CBLL), this is critical when scaling its AI brain diagnostic system. Optimal leverage will allow CeriBell, Inc. (CBLL) to implement innovative EEG sensors without threatening its financial stability.